The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System
Sean P. David, Lavisha Singh, Jaclyn Pruitt, Andrew Hensing, Peter J. Hulick, David O. Meltzer, Peter H. O’Donnell, Henry Mark Dunnenberger
This study examines the association between pharmacogenetic drug interactions and 90-day hospital readmissions, finding a 33% increased risk after adjusting for demographic and clinical factors.
Journal of Personalized Medicine · Nov 23, 2021Peer-reviewedGenetic & Genomic Medicine